Patients with cirrhosis, decompensation, and organ failure (so called acute-on-chronic liver failure, ACLF) portray disease-characterising immune dysregulation that, along with complications like hepatorenal syndrome, may present stimuli for higher KIM-1 release. The gene discussed is HAVCR1; the disease is liver disorder.